Tatva Chintan Pharma Chem Ltd vs Transpek Industry Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Tatva Chintan Pharma Chem Ltd is ₹ 1127 as of 20 Mar 15:30 . The P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 yearsThe P/E Ratio of Transpek Industry Ltd changed from 32.7 on March 2021 to 14.3 on March 2025 . This represents a CAGR of -15.25% over 5 years The Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 yearsThe Market Cap of Transpek Industry Ltd changed from ₹ 761.56 crore on March 2021 to ₹ 696.58 crore on March 2025 . This represents a CAGR of -1.77% over 5 years The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The revenue of Transpek Industry Ltd for the Dec '25 is ₹ 162.02 crore as compare to the Sep '25 revenue of ₹ 165.3 crore. This represent the decline of -1.98% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The ebitda of Transpek Industry Ltd for the Dec '25 is ₹ 28.47 crore as compare to the Sep '25 ebitda of ₹ 31.71 crore. This represent the decline of -10.22% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The net profit of Transpek Industry Ltd changed from ₹ 9.29 crore to ₹ 10.85 crore over 7 quarters. This represents a CAGR of 9.28% The Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 yearsThe Dividend Payout of Transpek Industry Ltd changed from 17.99 % on March 2021 to 22.94 % on March 2025 . This represents a CAGR of 4.98% over 5 years .

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

About Transpek Industry Ltd

Transpek Industry Limited is a leading global supplier for chlorinated products to various industry sectors ranging from Pharmaceuticals, Agrochemicals and dyes to pigments.
The Company has an excellent experience in manufacturing of products using chlorinated chemistry presenting unending opportunities for supply of intermediates and speciality chemicals suitable for multiple applications.
Presently, the Company is is into the manufacturing and export of a range of chemicals servicing the requirements of customers from a diverse range of industries - Textiles, Pharmaceuticals, Agrochemicals, Advanced Polymers, etc. Established in October, 1965, Transpek Industry Limited (TIL) went public in Sep.'78.
It started with the manufacture of acrylic plastic sheets at its plant at Atladra (Vadodra district), Gujarat.

FAQs for the comparison of Tatva Chintan Pharma Chem Ltd and Transpek Industry Ltd

Which company has a larger market capitalization, Tatva Chintan Pharma Chem Ltd or Transpek Industry Ltd?

Market cap of Tatva Chintan Pharma Chem Ltd is 2,637 Cr while Market cap of Transpek Industry Ltd is 553 Cr

What are the key factors driving the stock performance of Tatva Chintan Pharma Chem Ltd and Transpek Industry Ltd?

The stock performance of Tatva Chintan Pharma Chem Ltd and Transpek Industry Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Tatva Chintan Pharma Chem Ltd and Transpek Industry Ltd?

As of March 23, 2026, the Tatva Chintan Pharma Chem Ltd stock price is INR ₹1127.45. On the other hand, Transpek Industry Ltd stock price is INR ₹991.5.

How do dividend payouts of Tatva Chintan Pharma Chem Ltd and Transpek Industry Ltd compare?

To compare the dividend payouts of Tatva Chintan Pharma Chem Ltd and Transpek Industry Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.